Cargando…
Drug-microbiota interactions: an emerging priority for precision medicine
Individual variability in drug response (IVDR) can be a major cause of adverse drug reactions (ADRs) and prolonged therapy, resulting in a substantial health and economic burden. Despite extensive research in pharmacogenomics regarding the impact of individual genetic background on pharmacokinetics...
Autores principales: | Zhao, Qing, Chen, Yao, Huang, Weihua, Zhou, Honghao, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560686/ https://www.ncbi.nlm.nih.gov/pubmed/37806986 http://dx.doi.org/10.1038/s41392-023-01619-w |
Ejemplares similares
-
Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs
por: Feng, Wuwen, et al.
Publicado: (2020) -
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
por: Ahmed, Shabbir, et al.
Publicado: (2016) -
An Emergency Medicine Research Priority Setting Partnership to establish the top 10 research priorities in emergency medicine
por: Smith, Jason, et al.
Publicado: (2017) -
Refreshing the emergency medicine research priorities
por: Cottey, Laura, et al.
Publicado: (2023) -
Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine
por: Lê, Hélène, et al.
Publicado: (2022)